Literature DB >> 24395611

Comorbidity profile of chronic rhinosinusitis: a population-based study.

Shiu-Dong Chung1, Po-Yueh Chen, Herng-Ching Lin, Shih-Han Hung.   

Abstract

OBJECTIVES/HYPOTHESIS: This study aimed to explore the prevalence of a broad spectrum of comorbid medical conditions among patients with chronic rhinosinusitis (CRS), using a population-based dataset. STUDY
DESIGN: A cross-sectional study.
METHODS: In total, 5,734 CRS subjects and 17,202 comparison subjects were included in this study. Separate conditional logistic regression analyses were performed to calculate the odds ratio (OR) for each of 39 medical comorbidities between subjects with and without CRS.
RESULTS: For 27 of the 39 study comorbidities, results showed that subjects with CRS had a statistically significantly higher OR than subjects without CRS after adjusting for sociodemographic characteristics. Ranks of the top five comorbid relationships from the strongest ORs to the lowest were as follows: asthma (OR=3.09), chronic pulmonary disease (OR=3.04), weight loss (OR=2.58), obesity (OR=2.50), and migraines (OR=2.30).
CONCLUSION: Our results indicate that subjects with CRS have an increased prevalence of various comorbidities. LEVEL OF EVIDENCE: 3b.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Chronic rhinosinusitis; comorbidity

Mesh:

Year:  2014        PMID: 24395611     DOI: 10.1002/lary.24581

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  25 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Functional Comorbidity Index in chronic rhinosinusitis.

Authors:  Corinna G Levine; Greg E Davis; Edward M Weaver
Journal:  Int Forum Allergy Rhinol       Date:  2015-10-13       Impact factor: 3.858

3.  Association between computed tomography findings and clinical symptoms in chronic rhinosinusitis with and without nasal polyps.

Authors:  Tomislav Gregurić; Vladimir Trkulja; Tomislav Baudoin; Marko Velimir Grgić; Igor Šmigovec; Livije Kalogjera
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-02       Impact factor: 2.503

Review 4.  Sleep disruption in chronic rhinosinusitis.

Authors:  Mahboobeh Mahdavinia; Robert P Schleimer; Ali Keshavarzian
Journal:  Expert Rev Anti Infect Ther       Date:  2017-02-17       Impact factor: 5.091

5.  Association Between Middle Ear Cholesteatoma and Chronic Rhinosinusitis.

Authors:  Chin-Lung Kuo; Yu-Chun Yen; Wei-Pin Chang; An-Suey Shiao
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-08-01       Impact factor: 6.223

Review 6.  Role of Obesity in Otorhinolaryngologic Diseases.

Authors:  Su Young Jung; Dong Choon Park; Sang Hoon Kim; Seung Geun Yeo
Journal:  Curr Allergy Asthma Rep       Date:  2019-06-03       Impact factor: 4.806

7.  Correlation between systemic inflammatory response and quality of life in patients with chronic rhinosinusitis.

Authors:  Quinn Orb; Abigail Pulsipher; Kristine A Smith; Shaelene Ashby; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-18       Impact factor: 3.858

8.  The impact of endoscopic sinus surgery on total direct healthcare costs among patients with chronic rhinosinusitis.

Authors:  Patricia L Purcell; Sara Beck; Greg E Davis
Journal:  Int Forum Allergy Rhinol       Date:  2015-04-12       Impact factor: 3.858

9.  Social Factors in the Development of Chronic Rhinosinusitis: a Systematic Review.

Authors:  I Geramas; D Terzakis; E Hatzimanolis; C Georgalas
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-16       Impact factor: 4.806

10.  Five-year risk of incident disease following a diagnosis of chronic rhinosinusitis.

Authors:  A G Hirsch; X S Yan; A S Sundaresan; B K Tan; R P Schleimer; R C Kern; T L Kennedy; J S Greene; B S Schwartz
Journal:  Allergy       Date:  2015-09-25       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.